Navigation Links
BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University

- Opening celebrated with inaugural Symposium on Biofilms

CAMBRIDGE, Mass. and LUDWIGSHAFEN, Germany, April 29 /PRNewswire/ -- BASF today announced the official launch of the BASF Advanced Research Initiative at Harvard University. The Advanced Research Initiative at Harvard University represents an innovative model for university-industry collaboration designed specifically to drive new frontiers of scientific discovery. The opening of the initiative was celebrated with an inaugural two-day Symposium on Biofilms held in Cambridge, Massachusetts.

The decisive difference of this collaboration between academia and industry from most research initiatives is its more integrative nature: BASF researchers from Germany are working closely with Harvard academic research teams, easing scientific exchange on the projects, as well as fostering broader interaction between the two institutions. This arrangement also gives the students the opportunity to benefit from a close interaction and early exposure to industry. Harvard faculty will also have the freedom to distribute and publish findings from the initiative, and BASF will have the opportunity to further develop discoveries and innovations for possible commercialization.

Since the BASF Advanced Research Initiative at Harvard University was first announced last fall, 10 postdoctoral students from the United States, France, Italy, Switzerland and China have already started working in Harvard labs on multiple projects. For example, they are studying the interaction between bacteria and surfaces under various conditions and developing new types of surfaces in order to uncover structure-property relationships with respect to the interaction. Another project involves the use of colloidal techniques to develop formulations of pharmaceutical actives with a higher bioavailability. Over the next five years, with direct funding from BASF to reach up to $20 million, the students will pursue further projects in applied physics and mathematics, chemical biology, systems biology, bioengineering and materials science.

While based at Harvard's School of Engineering and Applied Sciences (SEAS), this highly interdisciplinary initiative will benefit from having strong ties with students, departments and schools throughout the University. In addition, relationships with other research groups at universities, such as Massachusetts Institute of Technology and the University of Massachusetts Amherst, as well as with technology transfer and other companies in New England, have already been established.

"We welcome the opportunity to work in cooperation with one of the world's most respected and prolific universities," said Dr. Andreas Kreimeyer, member of the Board of Executive Directors of BASF and Executive Research Director. "Together, we are the right team to harness the innovative potential of new technologies and translate them into commercial successes, while at the same time providing solutions to global challenges."

"This type of progressive research association with a major industrial leader is a new model for Harvard, and one we hope to emulate and repeat," said Venkatesh Narayanamurti, Dean, SEAS, John A. and Elizabeth S. Armstrong Professor, and Professor of Physics. "There is tremendous value in this initiative, as it will not only strengthen education and research, but also explore solutions to some of the world's most pressing problems in an effort to better society."

The two-day Symposium on Biofilms at the Norton's Woods Conference Center at the American Academy of Arts and Sciences in Cambridge, has brought together leading experts in microbiology, chemistry, physics and materials science, to share their knowledge about the life of biofilms and their interaction with surfaces. George Whitesides, Woodford L. and Ann A. Flowers University Professor, and Co-director of the BASF Advanced Research Initiative at Harvard University, delivered the keynote speech at the symposium.

The study of biofilms and their interaction with surfaces has gained worldwide interest as microbial biofilms on surfaces cause billions of dollars in losses each year in equipment damage, product contamination, and energy losses. More importantly, biofilms also cause medical infections, resulting in adverse and detrimental affect to human life.

In addition to Whitesides, BASF's Dr. Jens Rieger, Scientific Director of Polymer Research, and Harvard's David Weitz, Mallinckrodt Professor of Physics and Applied Physics, are directing the BASF Advanced Research Initiative at Harvard University and establishing a broad research network of faculty and students to generate new innovations relevant to society's needs.

About BASF

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost euro 58 billion in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at

SOURCE BASF Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
2. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
3. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
4. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
5. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
6. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
7. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
8. Hospital Launches Landmark Emergency Medicine Project
9. Watson Launches Generic Biaxin(R) XL
10. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
11. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Post Your Comments:
(Date:11/26/2015)... --> --> Juntendo University Hospital ... weighting of MRI for patients with Multiple Sclerosis (MS) ... with SyntheticMR in order to use SyMRI in clinical research ... generate multiple contrast images from a single scan and adjust ... it possible to both fine tune images and recreate additional ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the French Drugs ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... Wound Care Market by Type (Dressings, Therapy Devices, Active ... Facility, Out-Patient Facility), and Geography - Global Forecast to ... --> --> The purpose of ... forecast of the global advanced wound care market. It ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
Breaking Medicine News(10 mins):